Characterization of Junín virus particles inactivated by a zinc finger-reactive compound

Virus Research

Volumn 143, Issue 1, 2009, Pages 106-113

  García, Cybele C ^a   Ellenberg, Paula C ^a   Artuso, María C ^a   Scolaro, Luis A ^a   Damonte, Elsa B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Arenavirus; Jun n virus; Matrix protein; Virus inactivation; Zinc finger

Indexed keywords

DISULFIDE; DISULFIDE NSC20625; ENHANCED GREEN FLUORESCENT PROTEIN; FATTY ACID BINDING PROTEIN; HYBRID PROTEIN; MATRIX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROPHORESIS; ENDOSOME; GENETIC TRANSFECTION; HEMORRHAGIC FEVER; JUNIN VIRUS; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; ZINC FINGER MOTIF;

ANIMALS; ANTI-HIV AGENTS; ARENAVIRIDAE INFECTIONS; AZO COMPOUNDS; CARRIER PROTEINS; CERCOPITHECUS AETHIOPS; DISULFIDES; GREEN FLUORESCENT PROTEINS; JUNIN VIRUS; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEOCAPSID PROTEINS; RECOMBINANT FUSION PROTEINS; VERO CELLS; VIRION; VIRUS INACTIVATION; ZINC FINGERS;

ARENAVIRUS; JUNIN VIRUS;

EID: 67349181010     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.03.010     Document Type: Article

References (36)

1. Bachmann M.F., Bast C., Hengartner H., and Zinkernagel R.M. Immunogenicity of a viral model vaccine after different inactivation procedures. Med. Microbiol. Immunol. 183 (1994) 95-104
2. Berthoux L., Pechoux C., and Darlix J.-L. Multiple effects of anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication. J. Virol. 73 (1999) 10000-10009
3. Castilla V., Palermo L.M., and Coto C.E. Involvement of vacuolar proton ATPase in Junín virus multiplication. Arch. Virol. 146 (2001) 251-263
4. Compans R.W. Arenavirus ultrastructure and morphogenesis. In: Salvato M.S. (Ed). The Arenaviridae (1993), Plenum Press, New York 3-16
5. Cornu T.I., and de la Torre J.C. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75 (2001) 9415-9426
6. Cornu T.I., and de la Torre J.C. Characterization of the arenavirus RING finger protein regions required for Z-mediated inhibition of viral RNA synthesis. J. Virol. 76 (2002) 6678-6688
7. Damonte E.B. Junín virus. In: Creighton T.E. (Ed). Encyclopedia of Molecular Medicine (2002), John Wiley & Sons Inc., New York 1844-1846
8. Damonte E.B., and Coto C.E. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv. Virus Res. 58 (2002) 147-155
9. Eichler R., Strecker T., Kolesnikova L., ter Meulen J., Weissenhorn W., Becker S., Klenk H.D., Garten W., and Lenz O. Characterization of the Lassa virus matrix protein: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 100 (2004) 249-255
10. Enría D.A., and Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23 (1994) 23-31
11. Fisher-Hoch S.P., Ghorie S., Parker L., and Huggins J. Unexpected adverse reactions during a clinical trial in rural West Africa. Antiviral Res. 19 (1992) 139-147
12. Freed E.O. Viral late domains. J. Virol. 76 (2002) 4679-4687
13. García C.C., Candurra N.A., and Damonte E.B. Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antiviral Chem. Chemother. 11 (2000) 231-238
14. García C.C., Candurra N.A., and Damonte E.B. Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res. 55 (2002) 437-446
15. García C.C., Djavani M., Topisirovic I., Borden K.L.B., Salvato M.S., and Damonte E.B. Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds. J. Gen. Virol. 87 (2006) 1217-1228
16. Guinea R., and Carrasco L. Concanamycin A: a powerful inhibitor of enveloped animal virus entry into cells. Biochem. Biophys. Res. Commun. 201 (1994) 1270-1278
17. López N., Jácamo R., and Franze-Fernández M.T. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 75 (2001) 12241-12251
18. López N., Scolaro L., Rossi C., Jácamo R., Candurra N., Pujol C., Damonte E.B., and Franze-Fernández M.T. Homologous and heterologous glycoproteins induce protection against Junín virus challenge in guinea pigs. J. Gen. Virol. 81 (2000) 1273-1281
19. Marsh M., Bolzau E., and Helenius A. Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 32 (1983) 931-940
20. McCormick J.B., King I.J., Webb P.A., Scribner C.L., Craven R.B., Johnson K.M., Elliot L.H., and Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314 (1986) 20-26
21. Murphy F.A., and Whitfield S.G. Morphology and morphogenesis of arenaviruses. Bull. WHO 52 (1975) 409-419
22. Neuman B.W., Adair B.D., Burns J.W., Milligan R.A., Buchmeier M.J., and Yeager M. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79 (2005) 3822-3830
23. Okada A., Miura T., and Takeuchi H. Zinc- and pH-dependent conformational transition in a putative interdomain linker region of the influenza virus matrix protein M1. Biochemistry 42 (2003) 1978-1984
24. Perez M., Greenwald D.L., and de la Torre J.C. Myristoylation of the RING finger Z protein is essential for arenavirus budding. J. Virol. 78 (2004) 11443-11448
25. Perez M., Craven R.C., and de la Torre J.C. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. USA 100 (2003) 12978-12983
26. Rice W.G., Turpin J.A., Schaeffer C.A., Graham L., Clanton D., Buckheit Jr. R.W., Zaharevitz D., Summers M.F., Wallquist A., and Covell D.G. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 39 (1996) 3603-3616
27. Rice W.G., Turpin J.A., Huang M., Clanton D., Buckheit Jr. R.W., Covell D.G., Wallquist A., McDonnell N.B., de Guzman R.N., Summers M.F., Zalkow L., Bader J.P., Haugwitz R., and Sausville E.A. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat. Med. 3 (1997) 341-345
28. Rotz L.D., Khan A.S., Lillibridge S.R., Ostroff S.M., and Hughes J.M. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8 (2002) 225-230
29. Salvato M.S., Schweighofer K.J., Burns J., and Shimomaye E.M. Biochemical and immunological evidence that the 11-kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res. 22 (1992) 185-198
30. Salvato M.S. Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus. In: Salvato M.S. (Ed). The Arenaviridae (1993), Plenum Press, New York 133-156
31. Singh I., and Helenius A. Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J. Virol. 66 (1992) 7049-7058
32. Strecker T., Eichler R., ter Meulen J., Weissenhorn W., Klenk H.D., Garten W., and Lenz O. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles. J. Virol. 77 (2003) 10700-10705
33. Strecker T., Maisa A., Daffis S., Eichler R., Lenz O., and Garten W. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol. J. 3 (2006) 93
34. Tesh R.B., Jahrling P.B., Salas R., and Shope R.E. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am. J. Trop. Med. Hyg. 50 (1994) 452-459
35. Urata S., Noda T., Kawaoka Y., Yokosawa H., and Yasuda J. Cellular factors required for Lassa virus budding. J. Virol. 80 (2006) 4191-4195
36. York J., and Nunberg J.H. A novel zinc-binding domain is essential for formation of the functional Junín virus envelope glycoprotein complex. J. Virol. 81 (2007) 13385-13391